NIAID Banner Logo Image


1. 45274 HIV-LS-322; PUBMED-HIV-5/16/2005

Structure-Based Design: Synthesis and Biological Evaluation of a Series of Novel Cycloamide-Derived HIV-1 Protease Inhibitors

Ghosh, AK, Swanson, LM, Cho, H, Leshchenko, S, Hussain, KA, Kay, S, Walters, DE, Koh, Y, and Mitsuya, H

J Med Chem 2005. 48(10): 3576-3585


2. 45275 HIV-LS-322; PUBMED-HIV-5/16/2005

Stronger anti-HIV-1 activity of C-peptide derived from HIV-1(89.6) gp41 C-terminal heptad repeated sequence

Seo, JK, Kim, HK, Lee, TY, Hahm, KS, Kim, KL, and Lee, MK

Peptides 2005.


3. 45276 HIV-LS-322; PUBMED-HIV-5/16/2005

Newer aminopyrimidinimino isatin analogues as non-nucleoside HIV-1 reverse transcriptase inhibitors for HIV and other opportunistic infections of AIDS: design, synthesis and biological evaluation

Sriram, D, Bal, TR, and Yogeeswari, P

Farmaco 2005.


4. 45277 HIV-LS-322; EMBASE-OI-5/16/2005

Mesuol, a natural occurring 4-phenylcoumarin, inhibits HIV-1 replication by targeting the NF-[kappa]B pathway

Marquez, Nieves, Sancho, Rocio, Bedoya, Luis M, Alcami, Jose, Lopez-Perez, Jose Luis, Feliciano, Arturo San, Fiebich, Bernd L, and Munoz, Eduardo

Antiviral Research 2005. In Press, Corrected Proof


5. 45278 HIV-LS-322; EMBASE-OI-5/16/2005

2H-Pyrrolo[3,4-b] [1,5]benzothiazepine derivatives as potential inhibitors of HIV-1 reverse transcriptase

Di Santo, Roberto and Costi, Roberta

Il Farmaco 2005. In Press, Corrected Proof


6. 45279 HIV-LS-322; PUBMED-HIV-5/16/2005

Rare one and two amino acid inserts adjacent to codon 103 of the HIV-1 reverse transcriptase (RT) affect susceptibility to non-nucleoside RT inhibitors

Winters, MA, Kagan, RM, Kovari, L, Heseltine, PN, and Merigan, TC

Antivir Ther 2005. 10(2): 363-6


7. 45280 HIV-LS-322; PUBMED-HIV-5/16/2005

In vitro combination studies of tenofovir and other nucleoside analogues with ribavirin against HIV-1

Margot, NA and Miller, MD

Antivir Ther 2005. 10(2): 343-8


8. 45281 HIV-LS-322; PUBMED-HIV-5/16/2005

Phaseococcin, an antifungal protein with antiproliferative and anti-HIV-1 reverse transcriptase activities from small scarlet runner beans

Ngai, PH and Ng, TB

Biochem Cell Biol 2005. 83(2): 212-20


9. 45282 HIV-LS-322; PUBMED-HIV-5/16/2005

5-(3-Bromophenyl)-7-(6-morpholin-4-ylpyridin-3-yl)pyrido[2,3-d]pyrimidin-4 -ylamine: structure-activity relationships of 7-substituted heteroaryl analogs as non-nucleoside adenosine kinase inhibitors

Matulenko, MA, Lee, CH, Jiang, M, Frey, RR, Cowart, MD, Bayburt, EK, Didomenico, S, Gfesser, GA, Gomtsyan, A, Zheng, GZ, McKie, JA, Stewart, AO, Yu, H, Kohlhaas, KL, Alexander, KM, McGaraughty, S, Wismer, CT, Mikusa, J, Marsh, KC, Snyder, RD, Diehl, MS, Kowaluk, EA, Jarvis, MF, and Bhagwat, SS

Bioorg Med Chem 2005. 13(11): 3705-20


10. 45283 HIV-LS-322; EMBASE-OI-5/16/2005

Bioanalysis of HIV protease inhibitors in samples from sanctuary sites

Crommentuyn, KML, Huitema, ADR, and Beijnen, JH

Journal of Pharmaceutical and Biomedical Analysis 2005 . In Press, Corrected Proof


11. 45284 HIV-LS-322; EMBASE-OI-5/16/2005

HIV reverse transcriptase structures: designing new inhibitors and understanding mechanisms of drug resistance

Ren, Jingshan and Stammers, David K

Trends in Pharmacological Sciences 2005. 26(1): 4-7


12. 45285 HIV-LS-322; PUBMED-HIV-5/16/2005

Switching between Allosteric and Dimerization Inhibition of HIV-1 Protease

Bowman, MJ, Byrne, S, and Chmielewski, J

Chem Biol 2005. 12(4): 439-44


13. 45286 HIV-LS-322; EMBASE-OI-5/16/2005

Design, synthesis and biological evaluation of heteroaryl diketohexenoic and diketobutanoic acids as HIV-1 integrase inhibitors endowed with antiretroviral activity

Di Santo, R, Costi, R, Artico, M, Ragno, R, Greco, G, Novellino, E, Marchand, C, and Pommier, Y

Il Farmaco 2005. In Press, Corrected Proof


14. 45287 HIV-LS-322; EMBASE-OI-5/16/2005

Syntheses of new difluoromethylene benzoxazole and 1,2,4-oxadiazole derivatives, as potent non-nucleoside HIV-1 reverse transcriptase inhibitors

Medebielle, Maurice, Ait-Mohand, Samia, Burkhloder, Conrad, Dolbier, Jr William R, Laumond, Geraldine, and Aubertin, Anne-Marie

Journal of Fluorine Chemistry 2005. In Press, Corrected Proof


15. 45288 HIV-LS-322; WOS-HIV-5/8/2005

Synthesis of 3,4-disubstituted quinolin-2(1H)-ones via palladium-catalyzed regioselective cross-coupling reactions of 3-bromo-4-trifloxyquinolin-2(1H)-one with arylboronic acids

Wu, J, Zhang, L, and Sun, XY

CHEMISTRY LETTERS 2005. 34(4): 550-551, 2


16. 45289 HIV-LS-322; WOS-HIV-5/8/2005

Potent and selective inhibition of HIV-1 transcription by a novel naphthalene derivative

Wang, X, Yamataka, K, Okamoto, M, Ikeda, A, and Baba, M

ANTIVIRAL RESEARCH 2005. 65(3): A48-1


17. 45290 HIV-LS-322; WOS-HIV-5/8/2005

Exploring a new approach in AIDS therapy. Design, synthesis and biological evaluation of potential dimerization inhibitors of HIV-1 reverse transcriptase

Garcia-Aparicio, C, Rodriguez-Barrios, F, Gago, F, De, Clercq E, Balzarini, J, Camarasa, MJ, and Velazquez, S

ANTIVIRAL RESEARCH 2005. 65(3): A48-A49, 2


18. 45291 HIV-LS-322; WOS-HIV-5/8/2005

Inhibitors of HIV integrase: New diketo structures with heterocyclic scaffolds

Nair, V, Chi, GC, and Uchil, V

ANTIVIRAL RESEARCH 2005. 65(3): A50-1


19. 45292 HIV-LS-322; WOS-HIV-5/8/2005

Synthesis and study of 1-(2 '-deoxy-beta-D-ribofuranosy )-1,2,4-triazole-3-carboxamide as an anti-HIV-1 mutagenic agent

Vivet-Boudou, V, Paillart, JC, Burger, A, and Marquet, R

ANTIVIRAL RESEARCH 2005. 65(3): A51-1


20. 45293 HIV-LS-322; WOS-HIV-5/15/2005

Tosylation/mesylation of 4-hydroxy-3-nitro-2-pyridinones as an activation step in the construction of dihydropyrido[3,4-b] benzo[f][1,4]thiazepin-1-one based anti-HIV agents

Storck, P, Aubertin, AM, and Grierson, DS

TETRAHEDRON LETTERS 2005. 46(16): 2919-2922, 4


21. 45294 HIV-LS-322; WOS-HIV-5/15/2005

Glycyrrhizin inhibits R5 HIV replication in peripheral blood monocytes treated with 1-methyladenosine

Takei, M, Kobayashi, M, Li, XD, Pollard, RB, and Suzuki, F

PATHOBIOLOGY 2005. 72(3): 117-123, 7


22. 45295 HIV-LS-322; WOS-HIV-5/15/2005

Antiviral activity in vitro of Urtica dioica L., Parietaria diffusa K. and Sambucus nigra L

Manganelli, REU, Zaccaro, L, and Tomei, PE

JOURNAL OF ETHNOPHARMACOLOGY 2005. 98(3): 323-327, 5


23. 45296 HIV-LS-322; WOS-HIV-5/15/2005

A novel aspochalasin with HIV-1 integrase inhibitory activity from Aspergillus flavipes

Rochfort, S, Ford, J, Ovenden, S, Wan, SS, George, S, Wildman, H, Tait, RM, Meurer-Grimes, B, Cox, S, Coates, J, and Rhodes, D

JOURNAL OF ANTIBIOTICS 2005. 58(4): 279-283, 5


24. 45297 HIV-LS-322; WOS-HIV-5/15/2005

Large-scale conformational dynamics of the HIV-1 integrase core domain and its catalytic loop mutants

Lee, MC, Deng, JX, Briggs, JM, and Duan, Y

BIOPHYSICAL JOURNAL 2005. 88(5): 3133-3146, 14


If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: September 2023